Real-time enrollment status for this macular degeneration clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT06769048 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 138 participants |
| Active Locations | 42 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | February 18, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06769048 is currently active_not_recruiting participants. This clinical trial study for macular degeneration is not currently accepting new participants at 42 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06769048 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 42 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06769048 was last updated 1 week ago (February 18, 2026). HelloStudys verifies this status automatically.